Preparing for the Next Zika

April 29, 2016 

In the wake of the Ebola epidemic, governments have mobilized resources to support the development of vaccines and other biomedical countermeasures to emerging disease threats. Kendall Hoyt, Assistant Professor of Medicine at the Geisel School of Medicine and Dickey Global Health Affiliated Faculty, has published an opinion piece in Nature Biotechnology about the need for effective governance structures to coordinate countermeasure development

Hoyt, and her co-author Richard Hatchett, Acting Director of the Biomedical Advanced Research and Development Authority (BARDA), argue that lessons from US biodefense programs can inform global efforts.